Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Glide path describes how a target date fund changes its asset mix as the target year approaches, balancing risk and growth for your retirement.
25,488 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Stocks opened sharply lower on May 15, 2026, pushing the S&P 500 onto a heavier red backdrop as tech weakness and inf...
The healthcare sector is showing unexpected strength, beat-the-market moves, and renewed investor interest. This guid...
A retired couple aims to fund $14,500 in monthly expenses from a $2.5 million portfolio. The plan combines three inco...
Hyliion Holdings stock charged higher today as new analyst coverage and operational milestones sparked optimism. This...
AbbVie stock jumped today after the company disclosed a bold acquisition of Apogee Therapeutics for $10.9 billion. Th...
Fortinet sits at the center of a rapidly expanding cybersecurity market. This article explains why fortinet: strong i...
A powerful lineup in 2026 could redefine Disney's earnings trajectory. This article explains how disney's 2026 film s...
Broadcom stock rallied Thursday as AI-driven demand for semiconductor hardware pushed shares higher. This article bre...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Veteran trader Peter Brandt projects a Bitcoin price path to between 300,000 and 500,000, contingent on the four-year...
Investors are asking what the next five years hold for XRP. This guide breaks down plausible paths, key catalysts, ri...